Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.69) by 15.94 percent. This is a 30.95 percent increase over losses of $(0.84) per share from the same period last year.
Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate of $(0.69) by 15.94 percent. This is a 30.95 percent increase over losses of $(0.84) per share from the same period last year.
Comments